Apollo Cancer Institute treats a rare and complicated tumour, with robotic surgery for the first time in the Telugu states!
Hyderabad, 19th December, 2017 : Doctors at Apollo Cancer Institute led by Senior Surgical Oncologists, Dr Hemanth Vudayaraju and Dr Chinnababu Sunkavalli, performed a complicated Robotic surgery, spanning over four hours to remove a rare tumour called Aortocaval Paraganglionoma, causing serious life threatening complications to a 30 year old young man. This is the first such procedure attempted in the twin states of Telangana and Andhra Pradesh, for an extra adrenal tumour.
Aortocaval Paraganglionoma is a rare tumour that develops from cells outside the adrenal glands between the two main blood vessels of Vena Cava and Aorta, in close proximity of the critical nerves in the abdominal area. This tumour, which can be malignant in 40% cases, can occur in any age group, but is usually seen in young adults. These tumours have very short history due to dangerously high Blood Pressure and often present early. They require good clinical expertise to diagnose early. In the long run they can cause irreversible heart and kidney damage and lead to brain stroke.
The patient Mr B. Raju Naik, a Sales Officer by profession from Warangal, was in extreme distress, when he visited Apollo Cancer Institute. The tumour led to release of excessive hormones causing uncontrolled hypertension and consequently severe headache, convulsions, loss of vision, heart and kidney damage, within a short period of one month since the initial symptoms. He visited three different hospitals, which stabilised his unusually high BP with four medicines, diagnosed the ailment and referred to us for further treatment. However during this interim period he had episodes of siezure, unconsciousness, dizziness, visual disturbance.
The permanent cure for this problem is by Surgery, which was attempted after initial control of BP by many medicines. The surgery itself is very tricky and risky. The moment we touch the tumour, it will release hormones which impacts the BP of the patient. While administering anaesthesia and performing surgery, the BP can rapidly shoot up to dangerously high levels and abruptly fall to very low levels. Therefore an expert team of anaesthetists led by Dr G Shekhar Reddy, constantly monitored and deftly handled the situation during the course of the surgery. The case was also complicated because of the unusual location of the tumour in an area which is inaccessible and risky.
In this patient the tumour was embedded deep in the abdomen and densely struck on two major blood vessels of the body (IVC & Aorta), making it difficult for us to identify a safe approach to it. This prompted us to utilise the deft manoeuvrability offered by Robot to remove the tumour and we foresaw a better outcome with robotics than Laparoscopy or Open Laparotomy, says Dr Hemanth Vudayaraju.
The tumour was eventually removed by a robotic surgery approach in which 5 small incisions (1cm or less) were made and long instruments placed in the abdomen. The surgery was performed with the surgical Robot controlled by the surgeon instead of the usual Open Laparotomy approach which requires a 15 - 20 cm incision. The procedure lasted 4 hours. The patient has since recovered well from the procedure and was fit for discharge on the 3rd day, instead of the 10 days. Now, a week after the surgery he is totally off the hypertension medicines.
Robotic Surgery presents innumerable advantages to the surgeon and the patient, including magnified 3D vision, high instrument dexterity, high precision, small or no scars, less pain, rapid recovery, no wound related compilations, minimal blood loss, therefore no need for blood transfusions. Hospital and ICU stay for the patient is reduced, early recovery means rapid return to normalcy and work, says Dr Chinnababu Sunkavalli.
The patient Mr B. Raju Naik, who was seated along with the doctors at the press conference said, I am doing well and will be joining back in my job in a week's time.
About Apollo Hospitals
It was in 1983, that Dr. Prathap Reddy made a pioneering endeavour by launching India’s first corporate hospital - Apollo Hospitals in Chennai. Over the years Apollo Hospitals has established itself as home to the largest cardiac practice in India with over 160,000 cardiac surgeries. Apollo Hospitals is also the world’s largest private cancer care provider and runs the world’s leading solid organ transplant program.
As Asia’s largest and most trusted healthcare group, its presence includes 9,215 beds across 64 Hospitals, 2,500 Pharmacies, over 90 Primary Care and Diagnostic Clinics, 110 plus Telemedicine Centres and 80 plus Apollo Munich Insurance branches spanning the length and breadth of the Country.
As an integrated healthcare service provider with Health Insurance services, Global Projects Consultancy capability, over 15 medical education centres and a Research Foundation with a focus on global Clinical Trials, epidemiological studies, stem cell & genetic research Apollo Hospitals has been at the forefront of new medical breakthroughs with the most recent investment being that of commissioning the first Proton Therapy Center across Asia, Africa and Australia in Chennai, India. Every four days, the Apollo Hospitals Group touches a million lives, in its mission to bring healthcare of International standards within the reach of every individual.
In a rare honour, the Government of India issued a commemorative stamp in recognition of Apollos contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010. For more than 30 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Our hospitals are consistently ranked amongst the best hospitals globally for advanced medical services and research.
